Biopharmaceutical Excipients Market Enhance Growth of $2.7 Billion By 2025

San Francisco, 26 Mar 2019: The global biopharmaceutical excipients market size is expected to reach USD 2.7 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.08% over the forecast period. Rapid expansion of the biopharmaceutical industry due to increasing manufacturing capacities is one of the key driving force of this market. Rise in the number of protein therapeutics coupled with the presence of a substantial number of excipients to protect these proteins from degradation is also driving the market growth.

Investigational studies that are implemented for the impact analysis of excipient variability on in vitro dissolution testing are expected to reduce the attrition rate of final products and increase the reproducibility. These studies help scientists in gaining insights on the in vivo functioning and pharmacodynamic analysis of large molecules. The market exhibits continuous need of innovative excipient technologies to prolong the in vivo effectiveness of biologics and for improvement in the product delivery. Moreover, extensive R&D for the development of raw materials that help improve yields in mammalian cell-culture processes is expected to drive the market in future.

To request a sample copy or view summary of this report, click the link below: 
www.grandviewresearch.com/industry-analysis/biopharmaceutical-excipients-market

Further key findings from the study suggest:

• Easy availability and wide usage of dextrose, sucrose, and starch in biopharmaceutical formulations has resulted in the largest revenue share of carbohydrates
• Polyols is expected to be the fastest-growing product segment in the global biopharmaceutical excipients market
• This can be attributed to increasing concerns regarding protein degradation, which can be reduced by using polyols
• North America led the global market in 2017 accounting for the largest revenue share as a result of the presence of key biopharmaceutical manufacturers in U.S.
• Emerging markets, such as India and China, are projected to be driven by the contract manufacturers operating in these regions
• Some major biopharmaceutical excipient suppliers are Merck KGaA; Roquette; Clariant; DFE Pharma; SPI Pharma, Inc.; and JRS Pharma LP
• Most of these companies are engaged in establishing partnerships with biopharmaceutical manufacturers to understand their needs and develop raw materials specific to the process and end-product

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-biopharmaceutical-excipients-market

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Genomics Market Scale To Reach 27.6 Billion By 2025

San Francisco, 25 Mar 2019: The global genomics market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 9.1% over the forecast period. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the rising trend of targeted therapies.

Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and patients. This facilitates evidence-based decision-making, and hence, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools have motivated healthcare community to create precision-based therapies from surplus, available DNA data.

One of the most important factors, which are likely to have a significant impact on the market, is that how much and to what extent the medical community will make the use of available genomic information in personalized medicine. Furthermore, plummeting cost of sequencing has enabled the whole genome sequencing at very less price. Scientists are combining the sequencing generated data with diagnostics, which has proven its effectiveness in enhancing personalized treatment landscape.

The companies are involved in strategic alliances with global, as well as local, entities to boost their revenue generation and enhance their share in the market. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company. This enabled Bristol-Myers Squibb to deploy Foundation Medicine’s molecular information solutions and comprehensive genomic profiling for identification of predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials.

To request a sample copy or view summary of this report, click the link below: 
www.grandviewresearch.com/industry-analysis/genomics-market

Further key findings from the study suggest:

• Growing interest of pharma and biotech companies in genomics is expected to drive the genomics market in coming years
• NGS-based services held a major share of the market due to its rapid adoption in whole genome sequencing and application of sequence databases for disease screening and prognosis
• The demand for these services would remain strong due to growing customer base from academic and research centers to CROs and biotech and pharma companies
• Use of predictive biomarkers for diagnosis and monitoring takes cancer eradication a step further
• Moreover, various organizations and programs are actively participating in the development of novel biomarkers for cancer diagnosis
• With the rising health consciousness Direct-To-Consumer (DTC) laboratory testing is increasingly being employed. Such genetic tests enable consumers to access information about their genetics without having to visit healthcare professionals
• Asia Pacific is the potential regional market for genomics. It is anticipated to expand at the highest CAGR of 11.2%
• Major companies in the market include Beijing Genomics Institute (BGI); Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Foundation Medicine, Inc.; 23andMe, Inc.; Danaher, Illumina, Inc.; Pacific Biosciences; Oxford Nanopore Technologies; F. Hoffmann-La Roche Ltd.; and Myriad Genetics, Inc.

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/genomics-market-analysis

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Latest Trending Research Study on Metabolic Disorder Therapeutics Market Analysis 2014-2025

San Francisco, 25 Mar 2019: The global metabolic disorder therapeutics market size is expected to reach USD 88.93 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness a CAGR of 7.56% during the estimated period. Rising incidences of diabetes, obesity, and hypercholesterolemia are expected to drive the market growth. It is estimated that by 2040, about 1 person in 11 people worldwide is likely to suffer from one of the aforementioned diseases.

Researchers estimate that the prevalence of metabolic diseases like obesity and diabetes is expected to double in the coming 2 decades, mainly in U.S. and Asian and Latin American countries. This, in turn, will help boost the overall market growth in the year to come. Furthermore, with better economic stability in developing countries, demand for novel therapeutics for one-time treatment has increased. This has made major companies in the global market to invest heavily in R&D to develop innovative therapy options. All these factors will contribute to the development of the market.

To request a sample copy or view summary of this report: 
www.grandviewresearch.com/industry-analysis/metabolic-disorder-therapeutics-market

Further key findings from the study suggest:

• Diabetes segment led the market in 2017, in terms of revenue generation, owing to higher prevalence and drug usage
• Obesity segment is expected to register a CAGR of 9.27% over the forecast period owing to increasing prevalence as a result of sedentary lifestyle changes
• Drug therapy was the most-preferred therapy due to its high reliability proven success and availability of various types of drugs to treat metabolic diseases
• The segment is expected to maintain its dominance even during the forecast years due to the introduction of smart technology to deliver antidiabetic drug on a regulated basis
• Key companies in this market are Novo Nordisk A/S;Sanofi S.A.; BoehringerIngelheim GmbH; Eli Lilly and Company; Merck KgaA; Amgen, Inc.; AstraZeneca PLC; Actelion Pharmaceuticals Ltd.; Shire PLC; AbbVie, Inc.;Biocon Ltd.;BioMarinPharmaceutical, Inc.; Bristol-Myers Squibb Company; Cipla, Inc.; and CymaBay Therapeutics, Inc.
• Most of these companies are focusing on strategies, such as collaborations, expansion of product portfolios, and M&A to maintain their industry position
• Oral route of administration was the key revenue-generating segment in 2017owing to its benefits, such as high reliability and ease of administration
• North America was the largest regional market in 2017 and will maintain the trend in future due to the presence of key companies and rising cases of diabetes and obesity

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-metabolic-disorder-therapeutics-market

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Analysts Predict Lightning Growth for Global Agricultural Fumigants Market

San Francisco, 25 Mar 2019: The global agricultural fumigants market size is projected to reach USD 1.25 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 5.0% over the forecast period. Increasing demand of chloropicrin, 1,3-dichloropropene, phosphine, and metam sodium globally are the key driving forces for the market.

It is recommended to have professional applicators due to the hazardous characteristics of majority of the fumigants, especially dimethyl sulfide and chloropicrin. In economies that are majorly dependent on agricultural services and practices, the applicators are more often than not, government-appointed, or manufacturer deputed depending upon the nature of availability.

The importance of these products in reducing post-harvest losses is anticipated to be a key driver for the agricultural fumigants market. According to a report submitted by the World Health Organization (WHO), it has been observed that over one-third of food is wasted or lost due to improper storage. Reducing these losses may lower the pressure on agriculture industry to meet the dietary requirements of a growing population. Moreover, it shall also reduce the exploitation of other sustainable natural resources.

Fumigants that belong to the family of insecticides have been approved for the storage of food grains by the World Health Organization. The organization also carries out annual reviews to assess the toxicity of the existing products as well as the new products introduced in the market. The post-harvest phase, including storage and transportation, involves the use of fumigants for reducing storage losses.

To request a sample copy or view summary of this report: 
www.grandviewresearch.com/industry-analysis/agricultural-soil-fumigant-market

Further key findings from the report suggest:

• Although applications, such as warehousing and transportation hold a dominant market share, soil-based applications are projected to register a CAGR of 4.3% over the forecast period
• Liquid form of the product was the most widely used with around 35,000 tons used in 2017
• Majority of essential fumigants are organometallic derivatives obtained from chemicals, such as methylamine, carbon disulfide, methanethiol, and caustic soda
• Manufacturers such as BASF, Arkema, and AkzoNobel have integrated their operations by combining the manufacturing their chlor-alkali products along with formulating fumigants
• Some of the key participants in agricultural fumigants market are Arkema, Syngenta AG, Dow AgroSciences, and UPL among others. Regulations play vital role in shaping dynamics of companies, wherein new policies directly influence a company’s R&D purpose and introduction of new product classes.

Access press release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-agricultural-fumigants-market

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Global Threat Intelligence Market Is Thriving Worldwide 2014 – 2025

San Francisco, 22 Mar 2019: The global threat intelligence market is anticipated to reach USD 12.6 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for threat intelligence is increasing owing to rise in cyber-crime, threat breaches and growing numbers of sophisticated attacks in leading security conscious sectors. Moreover, the breaches in most of the organizations have a financial or espionage motive which results in disruption of business and has become a major concern for them which is expected to contribute to demand of threat intelligence solutions and services immensely.

Threat intelligence incident forensics is expected to gain traction over the forecast period. The application of incident forensics initiates actionable security during breach through predictive and reactive analysis. Further, its application investigates the root causes of the breach and contains the damage of an attack. An organization lacking to incorporate advanced intelligence system might pose as a key determinant that significantly affects the mass adoption of incident forensics solution.

Organizations are preferring the use of cloud security as the cost incurred in the implementation of the on-premise solutions is high. The cloud-based security adoption is expected to increase in the near future owing to the growing adoption of cloud storage systems. The cloud-based deployment stops the unwanted traffic before it enters the network. Furthermore, it eliminates the requirement of on-premise equipment, which is expected to increase the demand for the product over the forecast period.

To request a sample copy or view summary of this report: 
www.grandviewresearch.com/industry-analysis/threat-intelligence-market

Further key findings from the report suggest:

• The global threat intelligence market accounted for USD 3,028.9 million in 2016 and is expected to grow at a CAGR of 17.4% from 2017 to 2025
• The demand for incident forensics is estimated to reach USD 1,254.8 million by 2025 and is expected grow at a high rate over the forecast period.
• The cloud-based deployment in threat intelligence market is estimated to account USD 1,146.4 million in the year 2016.
• BFSI emerged as the largest application segment and is estimated to generate revenue over USD 3,282.0 million by 2025.
• Threat intelligence demand in manufacturing applications is anticipated to witness moderate growth over the forecast period.
• The Asia Pacific market is projected to witness substantial growth over the next decade owing to growing adoption of threat intelligence solutions on a large scale. The regional market is expected to grow at a CAGR of 21.1% from 2017 to 2025.
• Key players include IBM Corporation, Dell Inc., Symantec Corporation, Check Point Software Technologies Ltd., accounting for a majority share of the overall market in 2016.

Access Press Release Of This Research Report by Grand View Research: www.grandviewresearch.com/press-release/global-threat-intelligence-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com